← Back to home

NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO)

Clinical trials for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO) explained in plain language.

Never miss a new study

Get alerted when new NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO) trials appear

Sign up with your email to follow new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Massive data dive to map Germany's eye health

Knowledge-focused Not yet recruiting

This study aims to understand how common three serious eye diseases are in Germany and how treatment patterns have changed. Researchers will analyze existing health records from 50,000 people collected between 2009 and 2024. The goal is to map the occurrence of these diseases and…

Matched conditions: NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO)

Sponsor: Bayer • Aim: Knowledge-focused

Last updated Mar 20, 2026 14:47 UTC

NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO)

Get alerted when new NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO) trials appear

Massive data dive to map Germany's eye health